Fatchiyah Fatchiyah, Hardiyanti Ferlany, Widodo Nashi
Department of Biology, Faculty of Mathematics and Natural Sciences, University of Brawijaya, Jl Veteran, Malang, 65145, East Java, Indonesia.
Acta Inform Med. 2015 Apr;23(2):90-6. doi: 10.5455/aim.2015.23.90-96. Epub 2015 Apr 14.
Advanced Glycation End Products (AGE) play a pivotal role in the development various degenerative diseases such as diabetes, cardiovascular disease, stroke, neuropathy, and nephropathy. Different studies have been done to employ AGEs as drug targets for the diseases therapy. In previous study, we have found bioactive peptide from Ethawah goat milk for anti-diabetic that may work through inhibition of AGE receptor function. However, the mechanism of bioactive peptides inhibits AGE- AGE receptor (RAGE) bonding still not clear yet. Therefore we investigated the inhibition mechanism by calculate the potential energy binding among the peptides, AGEs and RAGE using molecular docking system.
Modeling 3D-structure was predicted by SWISS-MODEL web server. The virtual interaction was analyzed by docking system using HEX 8.0, Pymol and Discovery Studio 4.0 software.
this study showed that AGEs (Argypirimidine, Imidazole, Pentosidine and Pyrraline) bind to C-domain of RAGE. The total energy binding of RAGE with Argypirimidine, Imidazole, Pentosidine and Pyrraline were 378.35kJ/mol, -74.57kJ/mol, -301.25kJ/mol and -400.72kJ/mol, respectively. We have found three peptides among eight peptides from Ethawah goat milk, which are able bind to C-domain of RAGE, there are CSN1S2 f41-47, CSN1S2 f182-189, and CSN1S2 f214-221. The CSN1S22 f41-47 at arginine residue 47 interacts with proline162, leusine163 and leusine158 of RAGE. The total binding energy between CSN1S2 f41-47, CSN1S2 f182-189, and CSN1S2 f214-221 with RAGE were -378.35 kJ/mol, -359.97kJ/mol, -356.78 kJ/mol, respectively. Total binding energy and binding pattern indicated that RAGE more prefer bind with peptide and block AGE bind to functional site of RAGE. Further analysis showed that complex peptide-RAGE shifted binding site of AGE on function domain RAGE.
This study suggested that the peptides from Ethawah goat milk may act as an inhibitor of AGEs-RAGE interaction that impaired signal transduction cascade at the cellular level.
晚期糖基化终产物(AGE)在多种退行性疾病(如糖尿病、心血管疾病、中风、神经病变和肾病)的发展过程中起着关键作用。人们开展了不同的研究,将AGE用作这些疾病治疗的药物靶点。在之前的研究中,我们从伊塔瓦羊奶中发现了具有抗糖尿病作用的生物活性肽,其可能通过抑制AGE受体功能发挥作用。然而,生物活性肽抑制AGE与AGE受体(RAGE)结合的机制仍不清楚。因此,我们使用分子对接系统计算肽、AGE和RAGE之间的潜在能量结合,以研究其抑制机制。
通过SWISS-MODEL网络服务器预测三维结构模型。使用HEX 8.0、Pymol和Discovery Studio 4.0软件通过对接系统分析虚拟相互作用。
本研究表明,AGE(精氨嘧啶、咪唑、戊糖苷和吡咯赖氨酸)与RAGE的C结构域结合。RAGE与精氨嘧啶、咪唑、戊糖苷和吡咯赖氨酸的总能量结合分别为378.35kJ/mol、-74.57kJ/mol、-301.25kJ/mol和-400.72kJ/mol。我们从伊塔瓦羊奶中的八种肽中发现了三种能够与RAGE的C结构域结合的肽,即CSN1S2 f41-47、CSN1S2 f182-189和CSN1S2 f214-221。CSN1S22 f41-47在精氨酸残基47处与RAGE的脯氨酸162、亮氨酸163和亮氨酸158相互作用。CSN1S2 f41-47、CSN1S2 f182-189和CSN1S2 f214-221与RAGE的总结合能分别为-378.35 kJ/mol、-359.97kJ/mol、-356.78 kJ/mol。总结合能和结合模式表明,RAGE更倾向于与肽结合,并阻止AGE与RAGE的功能位点结合。进一步分析表明,肽-RAGE复合物改变了AGE在RAGE功能域上的结合位点。
本研究表明,伊塔瓦羊奶中的肽可能作为AGE-RAGE相互作用的抑制剂,在细胞水平上损害信号转导级联反应。